3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Pancreatic Neoplasms
6
Stomach Neoplasms
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Multiple Myeloma
2
Liver Neoplasms
2
Hepatoblastoma
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Anus Neoplasms
2
Wilms Tumor
1
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Thrombocytosis
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Penile Neoplasms
1
Ototoxicity
1
Neuroblastoma
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
Interventions
X-Rays
4
Phantoms, Imaging
4
Cyclophosphamide
4
fludarabine
3
Specimen Handling
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
talazoparib
2
selpercatinib
2
palbociclib
2
ivosidenib
2
Vemurafenib
2
Temozolomide
2
Sirolimus
2
Nuclear Medicine Department, Hospital
2
Nivolumab
2
LY3023414
2
Granulocyte Colony-Stimulating Factor
2
Busulfan
2
regorafenib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
omburtamab I-131
1
olaparib
1
larotrectinib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Vorinostat
×
Gastrointestinal
×
Clear all
NCT04308330
2026-04-15
NYMC195
New York Medical College
Phase 1
Recruiting
30 enrolled